Patents by Inventor Gabriele Jedlitschky

Gabriele Jedlitschky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070212366
    Abstract: The invention relates to the use of inhibitors of the multidrug resistance protein 4 (MRP4) in thrombocytes for the treatment and/or prophylaxis of cardiovascular diseases.
    Type: Application
    Filed: November 5, 2004
    Publication date: September 13, 2007
    Applicant: ERNST-MORITZ-ARNDT-UNIVERSITAT GREIFSWALD
    Inventors: Andreas Greinacher, Heyo Kroemer, Gabriele Jedlitschky
  • Patent number: 6673813
    Abstract: This invention provides a method of identifying and reversing multidrug resistance in a multidrug resistant tumor comprising administering a multidrug resistance reversing amount of any of the compounds as defined herein.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: January 6, 2004
    Inventors: Gabriele Jedlitschky, Inka Leier, Dietrich Keppler
  • Publication number: 20020013370
    Abstract: This invention provides a method of identifying and reversing multidrug resistance in a multidrug resistant tumor comprising administering a multidrug resistance reversing amount of any of the compounds as defined herein.
    Type: Application
    Filed: April 17, 2001
    Publication date: January 31, 2002
    Inventors: Jason Scott Sawyer, Stephen M. Spaethe, James Jacob Starling, Gabriele Jedlitschky, Inka Leier, Dietrich Keppler
  • Publication number: 20020010213
    Abstract: This invention provides a method of identifying and reversing multidrug resistance in a multidrug resistant tumor comprising administering a multidrug resistance reversing amount of any of the compounds as defined herein.
    Type: Application
    Filed: April 17, 2001
    Publication date: January 24, 2002
    Inventors: Jason Scott Sawyer, Stephen M. Spaethe, James Jacob Starling, Gabriele Jedlitschky, Inka Leier, Dietrich Keppler
  • Patent number: 6235785
    Abstract: This invention provides a method of identifying and reversing multidrug resistance in a multidrug resistance tumor comprising administering a multidrug resistance reversing amount of any of the compounds as defined herein.
    Type: Grant
    Filed: February 26, 1997
    Date of Patent: May 22, 2001
    Assignee: Eli Lilly and Company
    Inventors: Gabriele Jedlitschky, Inka Leier, Dietrich Keppler